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ABSTRACT
   Intracerebral hemorrhage (ICH) represents stroke characterized 
by formation and expansion of hematoma within brain parenchyma. 
Blood-derived factors released from hematoma are considered to be 
involved in poor prognosis of this disorder. We previously reported 
that thrombin, a blood derived serine protease, induced cytotoxicity 
in the cerebral cortex and the striatum in organotypic slice cultures, 
which depended on activation of mitogen-activated protein (MAP) 
kinase pathways and recruitment of microglia. Here we investigated 
the mechanisms of tissue injury associated with ICH involved multiple 
actions of thrombin on cells within the brain parenchyma, including 
activation of microglia as well as direct cytotoxicity on neurons. 
Today I will review the following 3 fi ndings that (1) thrombin and the 
activation of MAP kinases are involved in ICH-induced neuronal injury, 
and that neuroprotective effects of MAP kinases are in part mediated 
by arrestment of microglial activities, (2) p38 MAPK-dependent 
induction of heme oxygenase (HO)-1 supports survival of striatal 
microglia during thrombin insults, (3) nicotinic acetylcholine receptor 
stimulation exerts neuroprotective functions after long-term treatment.
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QOL (Quality of Life) の改善に繋がり、高齢化社会を迎える現代において重大なインパクトを
持つ。











ロンビンにより活性化されたPARは、protein kinase C (PKC)、
Src ファミリーチロシンキナーゼおよび mitogen-activated protein (MAP) キナーゼ経路の活性化
など、様々な細胞内シグナル伝達経路を駆動する 10)-12)。そのうち MAP キナーゼファミリー
には大きく分けて extracellular signal-regulated kinase (ERK)、p38 MAPK および c-Jun N-terminal 
kinase (JNK) の 3 種の主要なメンバーが含まれ、これらは細胞の分化・増殖あるいはアポトー
























クログリアにおいて MAP キナーゼファミリーの活性化が観察され、各 MAP キナーゼファミ
リー阻害薬の適用によってトロンビン毒性は軽減された。これらの知見は、in vitro 大脳皮質










クログリアのいずれにおいても ERK の活性化が観察された（data not shown）。アポトーシス
の指標の一つである TUNEL 陽性反応はニューロンにおいてのみ認められ、ミクログリアで







Fig.1 Involvement of thrombin and MAP kinase pathways in hemorrhagic injury. (A-D) 
Representative images of NeuN-immunostained coronal sections obtained 3 days after sham treatment 
(A and C) or 0.25 U collagenase injections (ICH; B and D). At low magnifi cation (A and B), a decrease 
in NeuN immunoreactivity was evident at hematoma region in ICH group. Magnifi ed views (C and 
D) reveal a substantial decrease in the number of NeuN-positive cells in the center of hematoma. (E, 
F, H-J) Shown are representative images of NeuN-immunostained coronal sections obtained 3 days 
after intrastriatal injection of collagenase (Col). The animals also received intracerebroventricular 
injections of vehicles, 2.5 μg argatroban (ARG; E), 10 nmol cycloheximide (CHX; F) or 5 nmol MAP 
kinase inhibitors (PD, SB, SP; H-J). Scale bar = 50 μm. (G, K) The number of neurons at center of 
hematoma. n=5-8 for each condition. ***P < 0.001 vs. sham group; #P < 0.05 vs. Col group. (L-O) OX42 
immunohistochemistry was done on brain sections obtained 3 day after collagenase injection. Animals 
also received intracerebroventricular injection of vehicle (DMSO; L) or MAP kinase inhibitors (PD, 
SB, SP; M-O). Scale bar = 50 μm. (P) The number of microglia in the periphery region of hematoma at 
3 days after collagenase injection. n=7-8 for each condition.
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３．トロンビン誘発活性化ミクログリアにおける HO-1 の役割
　　― Microglial Survival and HO-1 ―
　コラゲナーゼ微量投与によって作成した in vivo 脳内出血モデルおよび培養脳切片にトロン
ビンを適用した in vitro モデルを用いた解析において、MAP キナーゼファミリー阻害薬は、
線条体ミクログリアにおけるアポトーシス性細胞死を誘導し、それによって、ニューロンの
脱落に寄与する活性化ミクログリア数が減少することが見出された 16), 17)。
　一方、抗酸化酵素である heme oxygenase (HO)-1 の誘導機序として Nrf2-ARE 経路の他に
MAP キナーゼ活性化が関与していることが報告されており、ミクログリア系 BV-2 細胞に
HO-1 を発現させておくと、BV-2 細胞自身が種々の毒性因子（例えば、staurosporine、NO ドナー
など）に対して抵抗性を示すようになることや、出血後のマウス脳において血腫周辺領域の





　In vitro 大脳皮質 - 線条体切片培養系において、トロンビンによる HO-1 の発現誘導はニュー
ロンではなくグリア細胞において認められ、その発現は p38 MAPK 阻害薬によって有意に抑
制された。また、トロンビンによる p38 MAPK の活性化は、線条体のニューロンおよびミク
ログリアにおいてのみ認められた。さらに、HO-1 阻害薬である ZnPP Ⅸはミクログリアにア
ポトーシスを惹起し、トロンビン毒性を濃度依存的に軽減した。つまり、MAP キナーゼファ
ミリーのうち p38 MAPK は、線条体ミクログリア特異的に HO-1 の発現を誘導することによっ
てその生存を促進していることが示された（Fig. 2）21)。
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Fig.2 HO-1 contributes to pathology associated with thrombin-induced striatal and cortical injury 
in organotypic slice cultures. (A) Western blot analysis was performed on slice cultures that received 
100 U/ml thrombin treatment with or without 100 μM MAP kinase inhibitors (PD, SB, SP) for 24 h. (B) 
Summary of the effects of MAP kinase inhibitors on HO-1 expression. #P < 0.05 vs. thrombin alone. 
n=4. (C-E) Representative images of OX42-immunostained slices after 72 h of treatment with 100 U/ml 
thrombin. Where indicated, 0.3 μM ZnPP IX was concomitantly applied for 72 h. Scale bar = 100 μm. (F) 
Summary of the effect of ZnPP IX combined with thrombin on appearance of apoptotic nuclei in striatal 
microglia. The number of slices examined for each condition ranged between 9 and 12. ###P < 0.001 vs. 
thrombin alone. (G) Summary of the effect of ZnPP IX on thrombin-induced increase in the number 
of OX42-positive cells in the striatal region. The number of slices examined for each condition ranged 
between 12 and 18. ***P < 0.001 vs. control; ##P < 0.01 vs. thrombin alone. (H-M) Representative images 
of propidium iodide fl uorescence of whole slice cultures after 72 h of treatment with 100 U/ml thrombin 
in the absence and the presence of 0.3-3 μM ZnPP IX. Broken lines indicate areas of the cerebral cortex 
(Cx) and the striatum (St). Scale bar = 1 mm. (N) Summary of the effect of ZnPP IX on thrombin-
induced shrinkage of the striatal tissue. The number of slices examined for each condition ranged 
between 36 and 48. ***P < 0.001 vs. control; ##P < 0.01, ###P < 0.001vs. thrombin alone.
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４．ニコチン性アセチルコリン受容体長期刺激によるトロンビン毒性の制御










 そこで、in vitro 培養大脳皮質 - 線条体切片においてニコチンおよびアンタゴニスト
（α7;methyllycaconitine, α4; dihydro-β-erythroidine, non-selective; mecamylamine）を用いた解析を











Fig.3 Long-term treatment with nicotine suppresses neurotoxicity of, and microglial activation 
by, thrombin in cortico-striatal slice cultures. (A-D) Represent images of OX42-immunostained 
slices after 72 h treatment with 100 U/ml thrombin. Where indicated, nicotine was applied for the entire 
period of culture of 15 days. Scale bar = 50 μm. (E) Summary of the effects of nicotine on thrombin-
induced increase in the number of OX42-positive cells in the cortical region. Number of slices examined 
for each condition is 24-42. ***P < 0.001 vs. control; ###P < 0.001 vs. thrombin alone. (F, G) Images at 
a high magnifi cation of the region indicated by the solid line in panel B and C, respectively. Scale bar 
= 10 μm. (H-M) Representative images of propidium iodide fl uorescence of whole cultured slices after 
72 h treatment with 100 U/ml thrombin. The slices also received treatment with nicotine at indicated 
concentrations (3-30 μM) for the entire period of culture of 15 days. Broken lines denote area of the 
cerebral cortex and the striatum. Scale bar = 1 mm. (N) Summary of the effect of nicotine on thrombin-
induced cortical cell injury as assessed by the intensity of propidium iodide fl uorescence. Number of 
slices examined for each condition is 24-42. ***P < 0.001 vs. control; ###P < 0.001 vs. thrombin alone. 
(O-Q) Effects of 10 μM mecamylamine (O), 10 nM methyllycaconitine (MLA; P) and 10 nM dihydro-β-
erythroidine (DHβE; Q) on the effect of 10 μM nicotine against the increase of microglia in the cortical 
region induced by 72 h treatment with 100 U/ml thrombin. (R-T) Effects of 10 μM mecamylamine (R), 
MLA (S) and DHβE (T) on the protective effect of 10 μM nicotine against shrinkage of striatal tissue 
induced by 72 h treatment with 100 U/ml thrombin. Nicotine and nicotinic receptor antagonists were 
applied during the entire period of cultivation for 15 days. Number of slices examined for each condition 
is 24-41. ***P < 0.001 vs. control; ##P < 0.01, ###P < 0.001 vs. thrombin alone; +P < 0.05, ++P < 0.01
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